Scholars Central

Conference abstractPublished 2018

Ultrasound responsive proapoptotic drug delivery platform for image-guided therapeutics

Authors: Rajeet Chandan, Rinti Banerjee

Indian Institute of Technology, India

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Recently, liposomes-microbubble conjugates have emerged as a promising ultrasound (US)-responsive platform for cancer therapeutics. However, these are limited by their size in terms of tumor penetration. Additionally, there have been no attempts to enhance the smartness of the liposomes-bubble conjugates which have been used only as passive carriers. The present study explores submicron sized (756±180.0 nm), US-responsive, PhosphatidylSerine (PS)- based Paclitaxel-Liposomes-nanoBubble Conjugates (PSPLBC) with an additional pro-apoptotic effect towards enhanced anti-cancer efficacy and image-guidance. The developed PSPLBC underwent cavitation in response to US trigger, exhibiting in vitro pulsatile release with a 10-fold increase in cellular internalization as compared to control. The PS-containing formulations were found to be proapoptotic and exhibited strong synergism between PS and paclitaxel (Combination Index, CI < 0.1). This resulted in significantly high anti-tumor efficacy both in vitro and in vivo conditions (98.3±0.8% tumor growth inhibition, TGI) and 100% survival rate as compared to placebo control. Significant reduction in tumor proliferation index and microvessel density (MVD), as well as significant increase in apoptosis, were observed for the treated tumor sections. Further, the intravenous (IV) administration of PSPLBC enhanced the tumor US-contrast by 2-fold as compared to SonoVue®, a commercial ultrasound contrast agent (UCA), suggesting the image-guided therapeutic potential of the developed pro-apoptotic liposomenanobubble conjugates. These results show the potential of the developed liposomenanobubble conjugate as a sub-micron-sized, smart pro-apoptotic platform for US-image-guided and triggered delivery of a variety of drugs in case of various biomedical applications such as cancer.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pharmaceutics & Drug Delivery Research
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Rajeet Chandan”
  • BylineArticles whose byline prints “Rinti Banerjee”